532167 — Omkar Pharmachem Income Statement
0.000.00%
Last trade - 00:00
- IN₹225.90m
- IN₹230.00m
- IN₹5.40m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.45 | 2.7 | 5.4 | 5.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.83 | 2.51 | 2.49 | 2.74 | 2.32 |
Operating Profit | -3.83 | -2.06 | 0.208 | 2.66 | 3.08 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.21 | -2.6 | -0.359 | 2.1 | 2.65 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.2 | -2.6 | 2.21 | 1.83 | 1.98 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.2 | -2.6 | 2.21 | 1.83 | 1.98 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.2 | -2.6 | 2.21 | 1.83 | 1.98 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.417 | -0.257 | 0.22 | 0.182 | 0.196 |